• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肢端肥大症的全球流行病学:系统评价和荟萃分析。

Global epidemiology of acromegaly: a systematic review and meta-analysis.

机构信息

Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.

Department of Diagnostics and Public Health, University of Verona, Verona, Italy.

出版信息

Eur J Endocrinol. 2021 Jul 1;185(2):251-263. doi: 10.1530/EJE-21-0216.

DOI:10.1530/EJE-21-0216
PMID:34061771
Abstract

OBJECTIVE

To date, no systematic reviews and meta-analysis on the global epidemiology of acromegaly are available in the literature. The aims of this study are to provide a systematic review and a meta-analysis of the global epidemiology of acromegaly and to evaluate the quality of study reporting for the identified studies.

METHODS

MEDLINE, EMBASE and The Cochrane Library databases were searched for studies assessing the epidemiology of acromegaly from inception until 31 January 2020. We included original observational studies written in English, reporting acromegaly prevalence and/or incidence for a well-defined geographic area. Two reviewers independently extracted data and performed quality assessments. Prevalence and incidence pooled estimates were derived by performing a random-effects meta-analysis.

RESULTS

A total of 32 studies were included in the systematic review, and 22 of them were included in the meta-analysis. The pooled prevalence of acromegaly was 5.9 (95% CI: 4.4-7.9) per 100 000 persons, while the incidence rate (IR) was 0.38 (95% CI: 0.32-0.44) cases per 100 000 person-years. For both prevalence and IR, considerable between-study heterogeneity was found (I2 = 99.3 and 86.0%, respectively). The quality of study reporting was rated as the medium for 20 studies and low for 12 studies.

CONCLUSIONS

Although the largest amount of heterogeneity was due to the high precision of the studies' estimates, data source and geographic area could represent relevant study-level factors which could explain about 50% of the total between-study variability. Large-scale high-quality studies on the epidemiology of acromegaly are warranted to help the public health system in making decisions.

摘要

目的

目前,文献中尚无关于肢端肥大症全球流行病学的系统评价和荟萃分析。本研究旨在对肢端肥大症的全球流行病学进行系统评价和荟萃分析,并评估所确定研究报告的质量。

方法

检索 MEDLINE、EMBASE 和 Cochrane Library 数据库,以评估截至 2020 年 1 月 31 日肢端肥大症的流行病学研究。我们纳入了评估明确地理区域肢端肥大症患病率和/或发病率的原始观察性研究,报告采用英文撰写。两位审查员独立提取数据并进行质量评估。采用随机效应荟萃分析得出患病率和发病率的汇总估计值。

结果

系统评价共纳入 32 项研究,其中 22 项研究纳入荟萃分析。肢端肥大症的患病率汇总为 5.9(95%CI:4.4-7.9)/100000 人,而发病率(IR)为 0.38(95%CI:0.32-0.44)/100000 人年。患病率和发病率的研究间异质性均较大(分别为 I2 = 99.3%和 86.0%)。20 项研究的报告质量评分为中等,12 项研究的报告质量评分为低。

结论

尽管大部分异质性归因于研究估计值的高度精确性,但数据来源和地理区域可能代表了相关的研究水平因素,可解释总研究间变异性的约 50%。需要开展大规模高质量的肢端肥大症流行病学研究,以帮助公共卫生系统做出决策。

相似文献

1
Global epidemiology of acromegaly: a systematic review and meta-analysis.肢端肥大症的全球流行病学:系统评价和荟萃分析。
Eur J Endocrinol. 2021 Jul 1;185(2):251-263. doi: 10.1530/EJE-21-0216.
2
Global Cushing's disease epidemiology: a systematic review and meta-analysis of observational studies.全球库欣病流行病学:观察性研究的系统评价与荟萃分析
J Endocrinol Invest. 2022 Jun;45(6):1235-1246. doi: 10.1007/s40618-022-01754-1. Epub 2022 Feb 8.
3
Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis.全球杜氏肌营养不良症的流行病学:一项更新的系统评价和荟萃分析。
Orphanet J Rare Dis. 2020 Jun 5;15(1):141. doi: 10.1186/s13023-020-01430-8.
4
Global epidemiology of mucopolysaccharidosis type III (Sanfilippo syndrome): an updated systematic review and meta-analysis.全球黏多糖贮积症 III 型(Sanfilippo 综合征)的流行病学:一项更新的系统评价和荟萃分析。
J Pediatr Endocrinol Metab. 2021 Jul 19;34(10):1225-1235. doi: 10.1515/jpem-2020-0742. Print 2021 Oct 26.
5
Global prevalence and incidence of pressure injuries in hospitalised adult patients: A systematic review and meta-analysis.全球住院成年患者压力性损伤的患病率和发病率:系统评价和荟萃分析。
Int J Nurs Stud. 2020 May;105:103546. doi: 10.1016/j.ijnurstu.2020.103546. Epub 2020 Jan 31.
6
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
7
Epidemiology of chronic obstructive pulmonary disease in the global HIV-infected population: a systematic review and meta-analysis protocol.全球感染艾滋病毒人群中慢性阻塞性肺疾病的流行病学:一项系统评价和荟萃分析方案
Syst Rev. 2017 Mar 29;6(1):68. doi: 10.1186/s13643-017-0467-x.
8
Global Prevalence and Incidence of Tinnitus: A Systematic Review and Meta-analysis.全球耳鸣的患病率和发病率:系统评价和荟萃分析。
JAMA Neurol. 2022 Sep 1;79(9):888-900. doi: 10.1001/jamaneurol.2022.2189.
9
Global Prevalence and Incidence Estimates of Oral Lichen Planus: A Systematic Review and Meta-analysis.全球口腔扁平苔藓的患病率和发病率估计:系统评价和荟萃分析。
JAMA Dermatol. 2020 Feb 1;156(2):172-181. doi: 10.1001/jamadermatol.2019.3797.
10
Prevalence and incidence of hypertension in the global HIV-infected population: a systematic review and meta-analysis protocol.全球艾滋病毒感染人群中高血压的患病率和发病率:一项系统评价和荟萃分析方案
BMJ Open. 2017 Oct 12;7(10):e016531. doi: 10.1136/bmjopen-2017-016531.

引用本文的文献

1
Thoracic Back Pain Leading to an Acromegaly Diagnosis: A Case Report.因胸背部疼痛确诊肢端肥大症:一例报告
Cureus. 2025 Jun 7;17(6):e85533. doi: 10.7759/cureus.85533. eCollection 2025 Jun.
2
Global epidemiology of pheochromocytoma: a systematic review and meta-analysis of observational studies.嗜铬细胞瘤的全球流行病学:观察性研究的系统评价和荟萃分析
J Endocrinol Invest. 2025 Jul 2. doi: 10.1007/s40618-025-02639-9.
3
Effects of Treatment on Structural and Functional Parameters of the Left Heart in Naïve Acromegaly Patients: Prospective Single-Centre Study: 12-Month Follow-Up.
治疗对初诊肢端肥大症患者左心结构和功能参数的影响:前瞻性单中心研究:12个月随访
J Clin Med. 2025 May 13;14(10):3397. doi: 10.3390/jcm14103397.
4
Population Pharmacokinetic Analysis of an Octreotide Depot (CAM2029) in the Treatment of Acromegaly.奥曲肽长效注射剂(CAM2029)治疗肢端肥大症的群体药代动力学分析
Clin Pharmacokinet. 2025 May 26. doi: 10.1007/s40262-025-01522-3.
5
Cost-effectiveness analysis of second-line medical therapies in acromegaly: a real-life study.肢端肥大症二线药物治疗的成本效益分析:一项真实世界研究
Front Endocrinol (Lausanne). 2025 Apr 28;16:1573721. doi: 10.3389/fendo.2025.1573721. eCollection 2025.
6
Evaluation of pituitary tumor volume as a prognostic factor in acromegaly: A cross-sectional study in two centers.垂体瘤体积作为肢端肥大症预后因素的评估:一项在两个中心开展的横断面研究。
World J Radiol. 2025 Mar 28;17(3):100168. doi: 10.4329/wjr.v17.i3.100168.
7
Ectopic GHRH production: revisiting a rare cause of acromegaly.异位生长激素释放激素分泌:重新审视肢端肥大症的罕见病因。
Rev Endocr Metab Disord. 2025 Apr 2. doi: 10.1007/s11154-025-09961-w.
8
Cancer screening in patients with acromegaly: a plea for a personalized approach and international registries.肢端肥大症患者的癌症筛查:呼吁采用个性化方法并建立国际登记系统。
Rev Endocr Metab Disord. 2025 Mar 15. doi: 10.1007/s11154-025-09957-6.
9
Long-term clinical outcome of 103 patients with acromegaly after pituitary surgery.103例肢端肥大症患者垂体手术后的长期临床结局
Pituitary. 2025 Feb 22;28(2):33. doi: 10.1007/s11102-025-01503-6.
10
Impact of strict IGF1 control on quality-of-life scores in patients with acromegaly.严格控制胰岛素样生长因子1(IGF1)对肢端肥大症患者生活质量评分的影响。
Front Endocrinol (Lausanne). 2025 Jan 31;16:1516899. doi: 10.3389/fendo.2025.1516899. eCollection 2025.